A Phase Ii Safety And Efficacy Study Of Pm8002 (Anti-Pd-L1 X Vegf-A Bispecific) Combined With Paclitaxel As A Second-Line Therapy For Small Cell Lung Cancer (Sclc)
Paclitaxel;PM8002
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase Ii Safety And Efficacy Study Of Pm8002 (Anti-Pd-L1 X Vegf-A Bispecific) Combined With Paclitaxel As A Second-Line Therapy For Small Cell Lung Cancer (Sclc) ### Output: Paclitaxel;PM8002